Skip to Content
The 190th General Court of the Commonwealth of Massachusetts

Section 2E: Massachusetts AIDS Fund; expenditures

[ Text of section effective until April 11, 2017. For text effective April 11, 2017, see below.]

  Section 2E. The commissioner may expend amounts contained in the fund, with the advice and under the guidance of the AIDS advisory board, solely for research treatment, experimental treatment, and education related to acquired immune deficiency syndrome. Expenditures from the fund for such purposes shall complement and not replace existing local, state, or federal AIDS-related funding. The commissioner shall determine, with the advice and under the guidance of the AIDS advisory board, appropriate educational efforts to fund. The commissioner, after consultation with the AIDS advisory board, shall develop a list of research priorities and protocols. The commissioner shall make a priority of researching those drug and non-drug therapies that are not made generally available through federal and other state programs, and shall prioritize those therapies which show the most promise of combatting the HIV infection or its associated illnesses.

  No more than six percent of the amounts held in the fund in any one year shall be used for administration of the fund; provided, however, that this provision shall not preclude the appropriation from the General Fund of the commonwealth of additional amounts to support the administration of the fund. Notwithstanding any statute or regulations to the contrary, the commissioner may develop, with the advice of the AIDS advisory board, procedures for accepting proposals for implementing any of the purposes of the fund as set forth in this section.

Chapter 111: Section 2E. Massachusetts State Public Health and Hepatitis Fund; expenditures

[ Text of section as amended by 2016, 406, Sec. 4 effective April 11, 2017. For text effective until April 11, 2017, see above.]

  Section 2E. The commissioner may expend amounts contained in the fund, with the advice and under the guidance of the AIDS advisory board, solely for research treatment, experimental treatment and education related to viral hepatitis, HIV infection or its associated illnesses. Expenditures from the fund for such purposes shall complement and not replace existing local, state or federal viral hepatitis or AIDS-related funding. The commissioner shall determine, with the advice and under the guidance of the AIDS advisory board, appropriate educational efforts to fund. The commissioner, after consultation with the AIDS advisory board, shall develop a list of research priorities and protocols. The commissioner shall make a priority of researching those drug and non-drug therapies that are not made generally available through federal and other state programs and shall prioritize those therapies that show the most promise of combatting viral hepatitis, HIV infection or its associated illnesses.

  Not more than 6 per cent of the amounts held in the fund in any 1 year shall be used for administration of the fund; provided, however, that this shall not preclude the appropriation from the General Fund of additional amounts to support the administration of the fund. Notwithstanding any general or special law or regulation to the contrary, the commissioner may develop, with the advice of the AIDS advisory board, procedures for accepting proposals for implementing a purpose of the fund as set forth in this section.